Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
According to a regulatory filing, Sun Pharma will buy the entire issued and outs...
The approval follows a positive finding in the pivotal IRAKLIA Phase III study, ...
Inclusion based on S&P Global sustainability assessment covering global companie...
Acquisition to expand Aurobindo USA's portfolio of complex generics and U.S. man...
Embracing Wellness Beyond Healthcare Every year on June 21, the world comes toge...
Author Vijay Martis explains how Cipla's business model, strategy and purpose s...
The deal value comprises an upfront payment and further payments tied to the ach...
The partnership will bring together Voro Therapeutics’ tumour-activated biologic...
Two-day conference to focus on regulatory writing, AI governance, patient-centri...
The U.S. Department of Health and Human Services has posted more than $700 milli...
Executives from both organisations, including LG AI Research head Woohyung Lim a...
The collaboration involves up to $56m in upfront payments to AbCellera for the f...
Milind Sathe analyses how public regulatory dashboards can support pharmaceutic...
As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is...
Company receives US FDA approval and secures 180-day generic drug exclusivity fo...
Under the deal, Simulations Plus shareholders will receive $18.50 per share, rep...